Categorie -wet- en regelgeving

bv CGR, GDPR

wet- en regelgeving

EMA committee recommends approval of Dupixent for severe chronic rhinosinusitis with nasal polyposis

26 september 2019

Pharma Biz

wet- en regelgeving

Merck gets CHMP positive opinion for Rebif label amendment during pregnancy as clinically needed and while breastfeeding

26 september 2019

Pharma Biz

wet- en regelgeving

Bayer’s Vitrakvi receives first tumor-agnostic approval in EU

26 september 2019

Pharma Biz

wet- en regelgeving

EMA committee recommends marketing approval for Celltrion’s novel subcutaneous formulation of CT─P13 for RA treatment

25 september 2019

Pharma Biz

wet- en regelgeving technologie

OrthoSpin receives US FDA approval for smart, robotic external fixation system for orthopaedic treatments

23 september 2019

Pharma Biz

wet- en regelgeving

GSK’s oral nicotine spray wins divided FDA panel’s backing despite abuse risks

23 september 2019

FiercePharma

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer